Acotec Scientific Holdings Limited (HKG:6669)
13.59
+1.29 (10.49%)
Sep 5, 2025, 4:08 PM HKT
HKG:6669 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2020 |
592.85 | 533.99 | 473.85 | 395.55 | 303.81 | 193.98 | Upgrade | |
Revenue Growth (YoY) | 13.33% | 12.69% | 19.80% | 30.19% | 56.63% | 55.29% | Upgrade |
Cost of Revenue | 146.84 | 131.27 | 96.43 | 59.19 | 37.87 | 30.2 | Upgrade |
Gross Profit | 446.01 | 402.72 | 377.42 | 336.35 | 265.94 | 163.78 | Upgrade |
Selling, General & Admin | 167.52 | 157.71 | 181.32 | 160.51 | 116.89 | 104.69 | Upgrade |
Research & Development | 218.7 | 216.77 | 190.07 | 183.8 | 141.29 | 83.49 | Upgrade |
Other Operating Expenses | -20.85 | -9.35 | -16.92 | -7.1 | - | - | Upgrade |
Operating Expenses | 365.25 | 365.02 | 354.29 | 337.31 | 257.37 | 189.31 | Upgrade |
Operating Income | 80.76 | 37.71 | 23.13 | -0.96 | 8.57 | -25.53 | Upgrade |
Interest Expense | -8.83 | -9.9 | -9.83 | -1.42 | -3.82 | -1.42 | Upgrade |
Interest & Investment Income | 28.7 | 30.15 | 18.51 | 20.26 | 4.73 | 0.04 | Upgrade |
Earnings From Equity Investments | -0.98 | 0.1 | -0.6 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | -6.94 | -0.16 | -13.7 | 52.97 | -8.79 | 0.13 | Upgrade |
Other Non Operating Income (Expenses) | -0.83 | -1.61 | -0.13 | -0.34 | 6.69 | 4.61 | Upgrade |
EBT Excluding Unusual Items | 91.89 | 56.29 | 17.37 | 70.52 | 7.38 | -22.17 | Upgrade |
Gain (Loss) on Sale of Investments | 10.44 | 2.92 | -2.77 | -0.19 | -33.4 | 1.04 | Upgrade |
Gain (Loss) on Sale of Assets | -0.18 | -6.61 | -0.15 | -0.01 | -0.1 | 0 | Upgrade |
Other Unusual Items | - | - | - | - | -41.13 | -10.32 | Upgrade |
Pretax Income | 102.16 | 52.6 | 14.45 | 70.32 | -67.24 | -31.45 | Upgrade |
Income Tax Expense | 1.26 | 0.32 | -0.04 | 0.18 | 11.83 | 12.85 | Upgrade |
Earnings From Continuing Operations | 100.9 | 52.28 | 14.49 | 70.14 | -79.08 | -44.29 | Upgrade |
Minority Interest in Earnings | - | - | - | - | - | 0.45 | Upgrade |
Net Income | 100.9 | 52.28 | 14.49 | 70.14 | -79.08 | -43.84 | Upgrade |
Net Income to Common | 100.9 | 52.28 | 14.49 | 70.14 | -79.08 | -43.84 | Upgrade |
Net Income Growth | 214.58% | 260.88% | -79.35% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 301 | 301 | 301 | 300 | 248 | 186 | Upgrade |
Shares Outstanding (Diluted) | 301 | 301 | 301 | 300 | 248 | 186 | Upgrade |
Shares Change (YoY) | 0.01% | - | 0.49% | 20.78% | 33.16% | 13.17% | Upgrade |
EPS (Basic) | 0.34 | 0.17 | 0.05 | 0.23 | -0.32 | -0.24 | Upgrade |
EPS (Diluted) | 0.33 | 0.17 | 0.05 | 0.23 | -0.32 | -0.24 | Upgrade |
EPS Growth | 210.21% | 253.30% | -79.08% | - | - | - | Upgrade |
Free Cash Flow | - | 50.73 | -92.48 | -112.17 | -30.84 | -27.27 | Upgrade |
Free Cash Flow Per Share | - | 0.17 | -0.31 | -0.37 | -0.12 | -0.15 | Upgrade |
Gross Margin | 75.23% | 75.42% | 79.65% | 85.04% | 87.53% | 84.43% | Upgrade |
Operating Margin | 13.62% | 7.06% | 4.88% | -0.24% | 2.82% | -13.16% | Upgrade |
Profit Margin | 17.02% | 9.79% | 3.06% | 17.73% | -26.03% | -22.60% | Upgrade |
Free Cash Flow Margin | - | 9.50% | -19.52% | -28.36% | -10.15% | -14.06% | Upgrade |
EBITDA | 100.36 | 57.12 | 38.43 | 8.65 | 14.21 | -24.51 | Upgrade |
EBITDA Margin | 16.93% | 10.70% | 8.11% | 2.19% | 4.68% | -12.64% | Upgrade |
D&A For EBITDA | 19.6 | 19.42 | 15.3 | 9.6 | 5.64 | 1.02 | Upgrade |
EBIT | 80.76 | 37.71 | 23.13 | -0.96 | 8.57 | -25.53 | Upgrade |
EBIT Margin | 13.62% | 7.06% | 4.88% | -0.24% | 2.82% | -13.16% | Upgrade |
Effective Tax Rate | 1.23% | 0.61% | - | 0.25% | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.